Blood Systems Research Institute (BSRI)

Phone: 415-923-5771
Fax: 415 567-5899

Location(s): South Africa; China; India; Thailand; Brazil

Description

Blood Research Systems Institute (BSRI) has an outstanding record over the past 20 years of successfully conducting laboratory research projects for NIH and CDC-funded multi-center programs related to transfusion safety and infectious diseases. BSRI/BSL has played a key role in many of the major blood safety research programs from the early 1980s to the present. These multicenter studies have resulted in over 150 publications. These manuscripts clearly document the breadth and depth of BSRI's laboratory capacity, including the ability to develop and apply innovative specimen processing and analytical methods that addressed critical questions posed by investigators in these programs.

Archived Projects: 30

Project Investigator Topics Location Start End
Delete link
Retrovirus Epidemiology Donor Study (REDS) Edward L. Murphy, MD, MPH Infectious Disease, Health Systems Strengthening, Risk Reduction and Prevention
Pathophysiology of HTLV-I and HTLV-II Infection Edward L. Murphy, MD, MPH United States
XI International Conference on Human Retrovirology: HTLV Edward L. Murphy, MD, MPH HIV/AIDS United States
Natural History of Acute and Chronic HCV in Blood Donors Edward L. Murphy, MD, MPH Infectious Disease United States
Clinical Epidemiology of HTLV-I and HTLV-II Infection Edward L. Murphy, MD, MPH United States
Pathophysiology of HTLV-I and HTLV-II Infection Edward L. Murphy, MD, MPH United States
Sangre Segura: An Epidemiological Study of Blood Transfusion Safety in the Mexico-U.S. Border Region Edward L. Murphy, MD, MPH Infectious Disease, Health Systems Strengthening, Risk Reduction and Prevention Mexico; United States
Research Training in International Transfusion Safety Edward L. Murphy, MD, MPH Health Systems Strengthening, Training International Scholars and Clinicians South Africa; France; Honduras; Mexico; Argentina; Brazil
Retrovirus Epidemiology Donor Study-II (REDS-II) Central Laboratory Mark Seielstad, PhD Infectious Disease, Sexually Transmitted Infections (STIs), Health Systems Strengthening United States
Retrovirus Epidemiology Donor Study-II REDS-II International Component - Blood Center Edward L. Murphy, MD, MPH Infectious Disease, Health Systems Strengthening South Africa; China; Brazil
XV International Conference on Human Retrovirology: HTLV and Related Viruses Edward L. Murphy, MD, MPH Infectious Disease, HIV/AIDS United States
Retrovirus Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward L. Murphy, MD, MPH Epidemiology and Surveillance South Africa; China; Brazil
Mechanisms of Coagulation Abnormalities and Trauma Mitchell J. Cohen, MD Neurology and Mental Health, Trauma and PTSD United States
Prospective Observational Multi-Center Transfusion Study (PROMMTT) Mitchell J. Cohen, MD Trauma and PTSD United States
Timing and Mechanism of Traumatic Coagulopathy Mitchell J. Cohen, MD Surgery and Anesthesia, Trauma and PTSD United States
HIV Molecular Surveillance Satish K. Pillai, PhD HIV/AIDS United States
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Central Laboratory Mark Seielstad, PhD HIV/AIDS, Epidemiology and Surveillance United States
TO#1: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward L. Murphy, MD, MPH Infectious Disease, Systematic Reviews and Guideline Development, Epidemiology and Surveillance South Africa; China; Brazil
Antiviral Role of APOBEC3 in HIV/HCV Coinfected Patients Satish K. Pillai, PhD HIV/AIDS United States
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Hub Edward L. Murphy, MD, MPH HIV/AIDS, Epidemiology and Surveillance United States
Broad Spectrum Antivirals Targeting Envelope Proteolysis and Viral Uncoating Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development United States
RBC Storage Effect on Coagulation, Microparticles and Microchimerism in Critically Ill Patients Mitchell J. Cohen, MD Health Systems Strengthening United States
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay Christopher D. Pilcher, MD HIV/AIDS, Drug and Diagnostics Development United States
Genome-Wide Association Study to Examine Genes Associated with An Increased Risk of Febrile Seizure in Children Following Measles-Containing Vaccines Mark Seielstad, PhD Infectious Disease, Pharmacology and Drug Treatment, Pediatrics United States
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven G. Deeks, MD HIV/AIDS United States
Identifying Variants Casual for Type 2 Diabetes in Major Human Populations Mark Seielstad, PhD Diabetes South Korea; Singapore; Finland; United Kingdom
Genetics of Brazilian Populations Mark Seielstad, PhD Brazil
Health Outcomes in Blood Donors and Recipients Edward L. Murphy, MD, MPH Noncommunicable and/or Chronic Disease, Epidemiology and Surveillance, Risk Reduction and Prevention, Training and Capacity Building, Training International Scholars and Clinicians United States
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites - PHASE 2 Edward L. Murphy, MD, MPH United States
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Central Laboratory Mark Seielstad, PhD United States